查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084959

主動植入式醫療設備市場：2026-2032年全球市場預測（按器材類型、技術、病患年齡層、應用和最終用戶分類）

Active Implantable Medical Devices Market by Device Type, Technology, Patient Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，主動式植入式醫療設備市場規模將成長至 67.3 億美元，複合年成長率為 11.14%。

主要市場統計數據
基準年 2025 32.1億美元
預計年份：2026年 35.5億美元
預測年份 2032 67.3億美元
複合年成長率 (%) 11.14%

主動植入式醫療設備市場概覽

主動式植入醫療設備市場涵蓋植入式心臟整流去顫器神經刺激設備復律去顫器、人工電子耳、人工耳蝸、植入式輸液幫浦、心室輔助裝置和植入式監測平台。市場需求主要受已證實的臨床因素驅動。世界衛生組織指出，心血管疾病仍是全球首要死因，而由於聽力喪失、帕金森氏症、癲癇、慢性疼痛和糖尿病等疾病，符合植入式治療條件的患者族群也不斷擴大。

主動植入式醫療設備領域的變革性變化

主動植入式醫療設備領域正從以硬體為中心的植入式設備轉向高度互聯、數據豐富的治療系統。心臟節律管理設備擴大整合遠端患者監護和自動警報功能，而神經刺激平台則擴大支援針對慢性疼痛、運動障礙和癲癇的個人化程式設計。人工電子耳的創新也朝著改進語音處理、小型化外部組件以及增強與數位聽覺生態系統的整合方向發展。

人工智慧對植入式醫療設備的累積影響

人工智慧 (AI) 正整體成為主動植入式醫療設備領域的一股強大驅動力，尤其是在訊號解讀、治療最佳化、預測性維護和遠端監測工作流程方面。 AI 驅動的分析功能使臨床醫生能夠識別心律不整模式、檢測設備故障、微調神經刺激參數，並確定需要介入的患者的優先順序。

亞太、北美、歐洲和新興市場的關鍵區域洞察

北美憑藉其龐大的手術量、健全的保險報銷體系、先進的電生理基礎設施以及對遠端患者監護的早期應用，仍然是植入式醫療設備領域的領先地區。美國透過獲得FDA已通過核准的心臟節律管理、神經調控、人工電子耳、植入式幫浦和監護技術，引領區域創新；而加拿大則受益於其完善的醫院採購系統、公共醫療保健需求以及獲得結構化專科護理的便利。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協地區，醫療保健投資的增加、私立醫院網路的擴張以及對心臟病學和聽力學專科服務需求的成長，正在推動植入式心臟裝置、助聽器和神經刺激技術的應用。然而，價格可負擔性、全面的保險報銷以及獲得專科醫生診療的機會仍然是影響其應用的關鍵因素。在海灣合作理事會（GCC）國家，先進的三級醫療、醫療旅遊、國家衛生轉型策略以及數位醫療基礎設施正在為心臟病學、神經病學和聽力恢復領域的高階主動式植入醫療設備創造有利環境。

對主要主動植入式醫療設備市場關鍵國家的洞察

美國在先進有源植入式醫療設備的應用方面處於主導地位，這得益於其專業的心臟和神經醫學、完善的FDA核准流程、遠端監測的廣泛應用以及大量的臨床研究活動。加拿大則透過公共醫療採購和完善的醫院就診體系，維持穩定的需求。墨西哥則受益於私立醫院的成長、醫療旅遊的接近性以及與北美供應鏈的地理優勢。巴西擁有拉丁美洲最大的市場潛力，這主要得益於其沉重的心血管疾病負擔、專科醫療的擴張以及對心臟節律管理設備的既有需求。

為領先的有源植入式醫療設備領導企業提供的實用建議

產業領導企業應優先發展具有臨床差異化的主動式植入醫療設備，這些器械能夠減少併發症、延長電池壽命、提高磁振造影相容性、增強器械耐用性並實現安全的遠端監測。投資於實證醫學證據的收集，包括前瞻性研究、註冊研究、真實世界數據和衛生經濟學模型，對於證明降低住院率、提高生活品質和降低整體醫療成本至關重要。

調查方法

本執行摘要採用結構化的二級研究架構編寫，符合既定的醫療保健市場情報實踐。輸入資訊包括公開的監管指南、臨床實踐趨勢、同行評審文獻、政府衛生數據、產品核可、報銷方案趨勢、醫療保健基礎設施指標以及權威的公共衛生資訊來源。

結論：互聯植入式療法定義了發展的下一個階段。

主動式植入醫療設備正邁入一個以互聯醫療、人工智慧驅動的智慧、小型化技術、遠端監測和更完善的上市後課責為特徵的新階段。心血管疾病、神經系統疾病、聽力障礙、代謝性疾病和運動功能相關疾病的持續臨床需求，以及醫療保健系統對改善治療效果和長期疾病管理的持續關注，共同支持這一市場的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 主動植入式醫療設備市場：依器材類型分類

  • 心臟心律調節器
  • 人工電子耳
  • 植入式心臟整流去顫器
  • 點滴幫浦
  • 神經刺激設備

第8章 主動植入式醫療設備市場：依技術分類

  • 不可充電
  • 可充電的

第9章 主動植入式醫療設備市場：依病患年齡層分類

  • 成人
  • 老年人
  • 兒童

第10章 主動植入式醫療設備市場：依應用領域分類

  • 循環系統
    • 心臟衰竭管理
    • 心率節律管理
  • 內分泌學
  • 神經病學
    • 深部腦部刺激療法
    • 脊髓刺激療法
  • 耳科

第11章 主動植入式醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章 主動植入式醫療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 主動植入式醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 主動植入式醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Advanced Bionics Corporation
  • Aleva Neurotherapeutics SA
  • Axonics Modulation Technologies, Inc.
  • Berlin Heart GmbH
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Calon Cardio Ltd.
  • CARMAT SA
  • Cochlear Limited
  • CVRx Inc.
  • Envoy Medical Corporation
  • Inspire Medical Systems, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MED-EL Elektromedizinische Gerate GmbH
  • MicroPort CRM Corporation
  • MicroTransponder Inc.
  • Nevro Corp.
  • Nurotron Biotechnology Co., Ltd.
  • Oticon Medical A/S
  • Sonova Holding AG
  • SynCardia Systems LLC
  • William Demant Holding A/S
Product Code: MRR-4369010661A4

The Active Implantable Medical Devices Market is projected to grow by USD 6.73 billion at a CAGR of 11.14% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.21 billion
Estimated Year [2026] USD 3.55 billion
Forecast Year [2032] USD 6.73 billion
CAGR (%) 11.14%

Active Implantable Medical Devices Market Overview

The active implantable medical devices market covers electronically powered products that are fully or partly introduced into the body and intended to remain after the procedure, including cardiac pacemakers, implantable cardioverter defibrillators, neurostimulators, cochlear implants, implantable infusion pumps, ventricular assist devices, and implantable monitoring platforms. Demand is supported by verified clinical drivers: cardiovascular disease remains the leading global cause of death according to the WHO, while hearing loss, Parkinson's disease, epilepsy, chronic pain, and diabetes continue to expand the addressable patient population for implantable therapies.

Market development is increasingly shaped by miniaturization, rechargeable batteries, MRI-conditional designs, remote monitoring, closed-loop stimulation, and biocompatible materials. Hospitals, specialty clinics, ambulatory surgical centers, and electrophysiology labs are prioritizing active implantable medical devices that improve outcomes, reduce revision procedures, and support long-term patient management across value-based healthcare systems.

Transformative Shifts in the Active Implantable Device Landscape

The active implantable medical devices landscape is shifting from hardware-centric implants toward connected, data-rich therapeutic systems. Cardiac rhythm management devices now integrate remote patient monitoring and automated alerts, while neurostimulation platforms increasingly support personalized programming for chronic pain, movement disorders, and epilepsy. Cochlear implant innovation is also moving toward improved speech processing, smaller external components, and better integration with digital hearing ecosystems.

Regulatory expectations are transforming product development and lifecycle management. The EU Medical Device Regulation has increased clinical evidence, post-market surveillance, and traceability requirements, while the U.S. FDA continues to emphasize cybersecurity, software validation, real-world evidence, and device safety. These changes favor manufacturers with strong quality systems, clinical data capabilities, secure software governance, and robust post-market monitoring processes.

Cumulative Impact of Artificial Intelligence on Implantable Devices

Artificial intelligence is becoming a high-impact enabler across active implantable medical devices, particularly in signal interpretation, therapy optimization, predictive maintenance, and remote monitoring workflows. AI-assisted analytics can help clinicians identify arrhythmia patterns, detect device performance anomalies, refine neurostimulation parameters, and prioritize patients who need intervention.

The cumulative impact of AI is operational as well as clinical. Manufacturers are using machine learning in design verification, battery performance modeling, manufacturing quality control, and post-market surveillance. However, responsible adoption depends on transparent algorithms, validated datasets, cybersecurity controls, human oversight, and regulatory alignment for software as a medical device and AI-enabled decision support.

Key Regional Insights Across Asia-Pacific, North America, Europe, and Emerging Markets

North America remains a leading region for active implantable medical devices due to high procedure volumes, strong reimbursement pathways, advanced electrophysiology infrastructure, and early adoption of remote patient monitoring. The United States anchors regional innovation through FDA-cleared cardiac rhythm management, neuromodulation, cochlear, implantable pump, and monitoring technologies, while Canada benefits from established hospital procurement, public health system demand, and structured specialty-care access.

Europe is shaped by strong clinical expertise, MDR-driven evidence requirements, and broad adoption of cardiac and neurostimulation therapies across major economies. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in specialty care, aging-population management, digital health infrastructure, and domestic medtech capacity. Latin America, led by Brazil and Mexico, shows growing demand for implantable cardiac and hearing technologies but remains affected by reimbursement variability and uneven specialist access. The Middle East is advancing through tertiary-care investment, particularly in GCC health systems focused on cardiology, neurology, and medical tourism, while Africa presents long-term opportunity tied to infrastructure development, specialist training, public-private partnerships, and improved access to advanced surgical care.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, rising healthcare investment, expanding private hospital networks, and growing demand for specialty cardiology and audiology services are supporting adoption of implantable cardiac, hearing, and neurostimulation technologies, although affordability, reimbursement depth, and specialist availability remain key adoption factors. GCC countries are prioritizing advanced tertiary care, medical tourism, national health transformation strategies, and digital health infrastructure, creating favorable conditions for premium active implantable medical devices in cardiology, neurology, and hearing restoration.

The European Union is defined by harmonized regulatory oversight under MDR, strong clinical research networks, and reimbursement systems that reward demonstrated safety, clinical performance, and patient outcomes. BRICS markets combine large patient pools with increasing domestic manufacturing ambitions, especially in China, India, and Brazil, while Russia and South Africa remain influenced by procurement structures and access disparities. G7 countries continue to lead in high-value innovation, advanced clinical practice, remote monitoring adoption, and regulatory science. NATO-aligned markets benefit from resilient supply chain planning, cybersecurity focus, hospital modernization priorities, and heightened scrutiny of connected medical device security.

Key Country Insights for Major Active Implantable Device Markets

The United States leads in advanced active implantable medical device adoption, supported by specialized cardiac and neurological care, FDA pathways, remote monitoring penetration, and extensive clinical research activity. Canada demonstrates steady demand through public healthcare procurement and structured hospital access, while Mexico benefits from private hospital growth, medical tourism, and proximity to North American supply chains. Brazil is the largest Latin American opportunity, driven by cardiovascular disease burden, expanding specialty care, and established demand for cardiac rhythm management devices.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand for pacemakers, implantable cardioverter defibrillators, cochlear implants, ventricular assist devices, and neurostimulation systems, with Germany and France standing out for clinical capacity, reimbursement sophistication, and hospital-based technology adoption. Russia remains a complex market shaped by localization policies, procurement dynamics, and geopolitical constraints. In Asia-Pacific, China and India offer scale through large patient populations and expanding tertiary-care infrastructure, Japan and South Korea lead in advanced technology adoption and aging-population care models, and Australia maintains high clinical standards, specialist access, and uptake of advanced implantable therapies.

Actionable Recommendations for Active Implantable Device Leaders

Industry leaders should prioritize clinically differentiated active implantable medical devices that reduce complications, extend battery life, improve MRI compatibility, enhance device longevity, and enable secure remote monitoring. Investment in evidence generation is essential, including prospective studies, registries, real-world evidence, and health economic models that demonstrate reduced hospitalization, improved quality of life, and lower total cost of care.

Manufacturers should also strengthen cybersecurity-by-design, AI governance, supply chain resilience, regulatory intelligence, and clinician training. Partnerships with hospitals, payers, digital health providers, academic centers, and manufacturing partners can accelerate market access and support post-market performance. In emerging markets, tiered pricing, service support, local regulatory expertise, repair capacity, and physician education are critical to scaling adoption responsibly.

Research Methodology

This executive summary is developed using a structured secondary-research framework aligned with established healthcare market intelligence practices. Inputs include publicly available regulatory guidance, clinical practice trends, peer-reviewed literature, government health data, product approvals, reimbursement developments, healthcare infrastructure indicators, and recognized public health sources.

Insights are triangulated across demand drivers, technology trends, regional healthcare capacity, regulatory requirements, and competitive positioning. The methodology emphasizes verified qualitative and quantitative indicators rather than speculative claims, with attention to cardiovascular disease burden, neurological disorder prevalence, hearing health needs, implant procedure adoption, cybersecurity expectations, AI governance, and post-market safety requirements.

Conclusion: Connected Implantable Therapies Define the Next Growth Phase

Active implantable medical devices are moving into a new phase defined by connected care, AI-enabled intelligence, miniaturized engineering, remote monitoring, and stronger post-market accountability. The market is supported by durable clinical demand across cardiovascular, neurological, auditory, metabolic, and mobility-related conditions, as well as continued healthcare system focus on improved outcomes and long-term disease management.

Competitive advantage will increasingly depend on evidence-backed innovation, secure digital integration, regulatory readiness, clinical workflow fit, and regional execution. Organizations that combine clinical performance with patient-centered design, reliable supply chains, cybersecurity resilience, and scalable service models are best positioned to support adoption in mature and emerging healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Active Implantable Medical Devices Market, by Device Type

  • 7.1. Cardiac Pacemaker
  • 7.2. Cochlear Implant
  • 7.3. Implantable Cardioverter Defibrillator
  • 7.4. Infusion Pump
  • 7.5. Neurostimulator

8. Active Implantable Medical Devices Market, by Technology

  • 8.1. Non-Rechargeable
  • 8.2. Rechargeable

9. Active Implantable Medical Devices Market, by Patient Age Group

  • 9.1. Adult
  • 9.2. Geriatric
  • 9.3. Pediatric

10. Active Implantable Medical Devices Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Heart Failure Management
    • 10.1.2. Heart Rhythm Management
  • 10.2. Endocrinology
  • 10.3. Neurology
    • 10.3.1. Deep Brain Stimulation
    • 10.3.2. Spinal Cord Stimulation
  • 10.4. Otology

11. Active Implantable Medical Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals

12. Active Implantable Medical Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Active Implantable Medical Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Active Implantable Medical Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Advanced Bionics Corporation
  • 16.3. Aleva Neurotherapeutics S.A.
  • 16.4. Axonics Modulation Technologies, Inc.
  • 16.5. Berlin Heart GmbH
  • 16.6. BIOTRONIK SE & Co. KG
  • 16.7. Boston Scientific Corporation
  • 16.8. Calon Cardio Ltd.
  • 16.9. CARMAT SA
  • 16.10. Cochlear Limited
  • 16.11. CVRx Inc.
  • 16.12. Envoy Medical Corporation
  • 16.13. Inspire Medical Systems, Inc.
  • 16.14. Jarvik Heart, Inc.
  • 16.15. LivaNova PLC
  • 16.16. Medtronic plc
  • 16.17. MED-EL Elektromedizinische Gerate GmbH
  • 16.18. MicroPort CRM Corporation
  • 16.19. MicroTransponder Inc.
  • 16.20. Nevro Corp.
  • 16.21. Nurotron Biotechnology Co., Ltd.
  • 16.22. Oticon Medical A/S
  • 16.23. Sonova Holding AG
  • 16.24. SynCardia Systems LLC
  • 16.25. William Demant Holding A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INFUSION PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INFUSION PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OTOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OTOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OTOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 295. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 304. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)